관상동맥 폴리머 엔도스텐트 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 유형별, 용도별, 지역별, 경쟁별(2020-2030년)
Coronary Artery Polymer Endostents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application By Region & Competition, 2020-2030F
상품코드:1703398
리서치사:TechSci Research
발행일:2025년 04월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
관상동맥 폴리머 엔도스텐트 세계 시장 규모는 2024년 48억 2,000만 달러로 평가되었고, 2030년까지 연평균 성장률(CAGR) 5.20%로 예측 기간 동안 안정적인 성장이 예상됩니다.
이 시장은 헬스케어 산업에서 역동적이고 빠르게 발전하고 있는 분야로 관상동맥질환(CAD) 치료에 중요한 역할을 하고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
48억 2,000만 달러
시장 규모 : 2030년
65억 5,000만 달러
CAGR : 2025-2030년
5.20%
급성장 부문
PLLA
최대 시장
북미
심장에 혈액을 공급하는 동맥이 좁아지는 관상동맥 질환은 전 세계적으로 사망과 장애의 주요 원인이 되고 있습니다. 고분자 엔도스텐트는 기존의 관상동맥 우회술을 대체할 수 있는 최소 침습적 대안으로 획기적인 솔루션으로 등장했습니다. 생체적합성 폴리머로 만들어진 확장 가능한 소형 튜브인 이 첨단 의료기기는 막히거나 좁아진 관상동맥에 삽입되어 혈류를 회복하고 유지시켜 줍니다.
건강에 해로운 식습관, 좌식생활, 고령화 등 생활습관 요인으로 인해 CAD의 유병률이 증가하고 있는 것이 시장 확대의 주요 요인으로 작용하고 있습니다. 폴리머 스텐트는 일반적으로 혈관 성형술로 알려진 경피적 관상동맥 성형술(PCI)을 통해 도입됩니다.
기술 혁신은 약물 용출 능력 향상, 생체 흡수성 재료, 향상된 전달 메커니즘 등을 갖춘 차세대 고분자 내 삽입물의 개발로 이어지며 이 시장을 계속 형성하고 있습니다. 이러한 발전은 재협착(혈관 재협착)과 혈전증(혈전 형성)의 위험을 줄이고 조직의 빠른 치유와 통합을 지원하도록 설계되었습니다. 또한, 심혈관 위험 요인에 대한 인식이 높아지고 신흥 시장의 의료 인프라가 강화되면서 이 분야가 전 세계적으로 확대되고 있습니다.
The Global Coronary Artery Polymer Endostents Market was valued at USD 4.82 billion in 2024 and is projected to experience stable growth over the forecast period, with a compound annual growth rate (CAGR) of 5.20% through 2030. This market represents a dynamic and rapidly evolving segment within the healthcare industry, playing a critical role in the treatment of coronary artery disease (CAD).
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 4.82 Billion
Market Size 2030
USD 6.55 Billion
CAGR 2025-2030
5.20%
Fastest Growing Segment
PLLA
Largest Market
North America
Coronary artery disease, characterized by the narrowing of the arteries that supply blood to the heart, continues to be a leading cause of death and disability worldwide. Polymer endostents have emerged as a transformative solution, offering a minimally invasive alternative to conventional coronary artery bypass surgery. These advanced medical devices-small, expandable tubes made from biocompatible polymers-are inserted into blocked or narrowed coronary arteries to restore and maintain blood flow.
The increasing prevalence of CAD, driven by lifestyle factors such as unhealthy diets, sedentary behavior, and an aging global population, is a primary factor fueling market expansion. Polymer endostents are typically deployed through percutaneous coronary intervention (PCI), commonly known as angioplasty, a widely adopted procedure due to its efficiency and shorter recovery times compared to surgical approaches.
Technological innovations continue to shape this market, leading to the development of next-generation polymer endostents with improved drug-eluting capabilities, bioabsorbable materials, and enhanced delivery mechanisms. These advancements are designed to reduce the risks of restenosis (vessel re-narrowing) and thrombosis (blood clot formation) while supporting faster tissue healing and integration. Additionally, rising awareness of cardiovascular risk factors and the strengthening of healthcare infrastructure in emerging markets are contributing to the sector's global expansion.
Key Market Drivers
Rising Prevalence of Coronary Artery Disease (CAD)
The growing incidence of CAD is a major driver behind the expansion of the Coronary Artery Polymer Endostents Market. CAD is the foremost cause of mortality globally, responsible for an estimated 17.9 million deaths annually-approximately 85% of which are due to heart attacks and strokes. According to the World Health Organization (WHO), addressing risk factors such as hypertension, obesity, and diabetes is essential to reducing premature deaths and alleviating the global healthcare burden caused by cardiovascular diseases.
In 2022, the estimated number of active CAD cases reached 315 million worldwide, highlighting the scale of this public health challenge. Sedentary lifestyles, poor dietary habits, smoking, and a rising incidence of comorbid conditions have all contributed to this increase. Consequently, there is a growing demand for effective and minimally invasive treatment options like coronary artery polymer endostents.
These stents offer a less invasive solution compared to traditional bypass surgery, functioning as internal scaffolds to keep arteries open while also delivering drugs that help prevent complications such as restenosis and thrombosis. Their use translates into shorter hospital stays, quicker recovery times, and fewer post-operative complications.
As healthcare systems increasingly focus on cost-effective and efficient treatment methods, polymer endostents are gaining favor for their clinical effectiveness and economic viability. Their minimally invasive nature aligns with the healthcare industry's shift toward outpatient care and same-day discharge protocols. Furthermore, the aging population-more vulnerable to CAD-underscores the importance of expanding access to such advanced treatment solutions.
Key Market Challenges
Regulatory Barriers
Despite significant technological progress and the increasing importance of polymer endostents in CAD management, the market faces several regulatory challenges that may impede growth. The medical device approval landscape is complex and varies significantly across global regions. Regulatory authorities such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other national bodies impose distinct and often rigorous requirements for market access.
This lack of regulatory harmonization results in extended approval timelines and elevated development costs. Manufacturers must navigate a demanding approval process, which includes extensive preclinical and clinical testing, as well as comprehensive documentation. Although these requirements ensure patient safety and product efficacy, they also delay commercialization and inflate operational expenses.
Moreover, regional discrepancies in regulatory expectations compel manufacturers to tailor their submissions for individual markets, adding further complexity to global expansion efforts. This fragmented regulatory landscape remains a key obstacle to the broader adoption and availability of coronary artery polymer endostents.
Key Market Trends
Advancement of Minimally Invasive Procedures
The increasing adoption of minimally invasive procedures is significantly contributing to the growth of the Coronary Artery Polymer Endostents Market. These approaches have revolutionized the treatment paradigm for CAD, offering both patients and providers a less intrusive and more efficient alternative to traditional surgery.
Polymer endostents are central to these procedures, deployed through catheter-based techniques rather than open-heart surgery. This method minimizes physical trauma, leading to less pain, reduced blood loss, and faster recovery. Patients benefit from shorter hospital stays and a quicker return to daily activities, ultimately improving quality of life.
Clinically, minimally invasive techniques enhance procedural precision, allowing cardiologists to navigate complex vascular anatomies with greater ease and safety. These procedures also tend to have fewer complications and shorter durations, making them increasingly attractive in busy healthcare settings.
The trend toward minimally invasive interventions, combined with ongoing product innovation and improved patient outcomes, is expected to continue propelling the coronary artery polymer endostents market forward.
Key Market Players
Eucatech AG
MicroPort Scientific Corporation
Rontis Medical
Meril Life Sciences
Alvimedica Medical Technologies
InSitu Technologies
Elixir Medical
SINOMED Inc
Amaranth Medical Inc
Amg International
Report Scope:
In this report, the Global Coronary Artery Polymer Endostents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Coronary Artery Polymer Endostents Market, By Type:
PLGA
PLLA
PDLA
Deamination Tyramine Polycarbonateeucatech
Coronary Artery Polymer Endostents Market, By Application:
Acute Myocardial Infarction
Acute Vascular Blockage
Other
Coronary Artery Polymer Endostents Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Coronary Artery Polymer Endostents Market.
Available Customizations:
Global Coronary Artery Polymer Endostents market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Coronary Artery Polymer Endostents Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (PLGA, PLLA, PDLA, Deamination Tyramine Polycarbonateeucatech)
5.2.2. By Application (Acute Myocardial Infarction, Acute Vascular Blockage, Other)
5.2.3. By Company (2024)
5.2.4. By Region
5.3. Market Map
6. North America Coronary Artery Polymer Endostents Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Application
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Coronary Artery Polymer Endostents Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Application
6.3.2. Mexico Coronary Artery Polymer Endostents Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Application
6.3.3. Canada Coronary Artery Polymer Endostents Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Application
7. Europe Coronary Artery Polymer Endostents Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Application
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Coronary Artery Polymer Endostents Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Application
7.3.2. Germany Coronary Artery Polymer Endostents Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Application
7.3.3. United Kingdom Coronary Artery Polymer Endostents Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Application
7.3.4. Italy Coronary Artery Polymer Endostents Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Application
7.3.5. Spain Coronary Artery Polymer Endostents Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Application
8. Asia-Pacific Coronary Artery Polymer Endostents Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Application
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Coronary Artery Polymer Endostents Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Application
8.3.2. India Coronary Artery Polymer Endostents Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Application
8.3.3. South Korea Coronary Artery Polymer Endostents Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Application
8.3.4. Japan Coronary Artery Polymer Endostents Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Application
8.3.5. Australia Coronary Artery Polymer Endostents Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Application
9. South America Coronary Artery Polymer Endostents Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Application
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Coronary Artery Polymer Endostents Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Application
9.3.2. Argentina Coronary Artery Polymer Endostents Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Application
9.3.3. Colombia Coronary Artery Polymer Endostents Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Application
10. Middle East and Africa Coronary Artery Polymer Endostents Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Application
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Coronary Artery Polymer Endostents Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Application
10.3.2. Saudi Arabia Coronary Artery Polymer Endostents Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Application
10.3.3. UAE Coronary Artery Polymer Endostents Market Outlook
